跳至主要内容
临床试验/CTRI/2021/05/033905
CTRI/2021/05/033905已完成未知

Clinicopathological study of gastric carcinoma with special reference to ERK 1/2 and Bcl-2: anobservational study in a tertiary care cancer hospital.

Chittaranjan National Cancer Institute0 个研究点目标入组 63 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients who will be operated for gastric neoplasm and will be diagnosed with malignant
  • gastric epithelial neoplasms histopathologically.
  • 2. Those who will give informed consent for taking part in the study.

排除标准

  • 1. After histopathological diagnosis all benign gastric neoplasms will be excluded.
  • 2. After histopathological diagnosis gastric neoplasms other than malignant gastric epithelial
  • neoplasms will be excluded.
  • 3. Cases where Neoadjuvant chemotherapy have been administered.
  • 4. Those who are not willing to take part in the study.

研究者

相似试验

Study of tumor markers in terms of their importance... | 临床试验